Latest News
MarketAxess has appointed Spencer Lee, the Co-Founder of systematic credit hedge fund firm Agilon Capital, as its new Head of Client Products, Americas, with effect from 12 May, according to a report by Asset Servicing Times.
Digital Prime Broker Sage Capital Management has appointed Chris Mills as Head of Digital Assets. Mills joins from JB Drax Honore, where he was Co-Head of Digital Assets, with responsibilities for product development and trade execution.
Millennium Management, one of the world’s largest multi-strategy hedge funds, is exploring a potential minority stake sale in its management company and is in discussions with Goldman Sachs’ Petershill Partners to assist in the process, according to a Financial Times report.
Hedge funds delivered mixed results in April, with equity hedge strategies leading the way as they navigated a month marked by historic market volatility and sharp swings in investor sentiment, according to data from Hedge Fund Research.
GAM Investments has ceded full control of its jointly managed catastrophe bond hedge fund to Fermat Capital Management, resolving a months-long dispute that had unsettled investors and significantly reduced the fund’s assets, according to a report by CityWire.
The proxy fight between Harley-Davidson and activist hedge fund H Partners has intensified ahead of the company’s 14 May annual meeting, with major proxy advisory firms split over the future of the motorcycle maker’s board.
Activist hedge fund Glenview Capital has reduced its stake in CVS Health after the insurer reported robust first-quarter results and a raised 2025 earnings outlook, the firm disclosed on Tuesday, according to a report by Reuters.
Phil King, Co-Founder and CIO of Regal Partners, has acknowledged the misjudgment behind the firm’s high-profile investment in Opthea Ltd, which has been written down to zero, but says the biotech blowup has not triggered any investor redemptions, according to a report by Bloomberg.
Paul Tudor Jones, founder of macro-focused hedge fund firm Tudor Investment Corporation, expects US President Donald Trump to reduce tariffs on Chinese goods by 50%, but says such a move may not be enough to prevent equity markets from retesting recent lows, according top a report by Bloomberg.
Activist hedge fund Farallon Capital Management has deepened its involvement with Japanese pharmaceutical giant Astellas Pharma, prompting the company’s leadership to publicly acknowledge ongoing engagement efforts, according to a report by Bloomberg.
